Task: Please answer the following question about the molecule with SMILES NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.